A new integrated technology-driven screening approach will enable women to get tested for cervical cancer in the comfort of their own homes – a pioneering effort to detect cervical cancer in its early stages.
ROSE (Removing Obstacles to Cervical Screening), the world’s first cervical screening programme featuring self-sampling by women themselves, is a human papilloma virus (HPV) DNA test – rather than a Pap smear diagnostic test that uses microscopy – and is based on an e-health platform.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!